MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Cerebrospinal fluid biomarkers for diagnosis of Parkinson’s disease: a systematic review and network meta-analysis

    SM. Li, YC. Zheng, C. Yang, JY. Wu, ZW. Yu, Y. Jiang, T. Feng (Beijing, China)

    Objective: In this study, we intended to use network meta-analysis to compare the diagnostic performances of different CSF biomarkers in the diagnosis and differential diagnosis…
  • 2023 International Congress

    Salivary α-synuclein in Parkinson’s disease – a pilot study

    M. Kaiserova, D. Hrabos, M. Levkova, M. Kavalkova, R. Kopacik, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: The aim of our study was to measure total salivary α-synuclein in Parkinson´s disease (PD) patients to assess its potential as a biomarker of…
  • 2023 International Congress

    Physical exercise as a promising option for treating fatigue in Parkinson’s disease? Results of a systematic review and meta-analysis of non-pharmacological interventions

    A. Folkerts, J. Nielsen, R. Gollan, A. Lansu, D. Solfronk, I. Monsef, N. Skoetz, K. Zeuner, E. Kalbe (Cologne, Germany)

    Objective: To give an update on randomized controlled trials (RCT) including non-pharmacological intervention approaches that examine effects on fatigue in people with Parkinson’s disease (PD).…
  • 2023 International Congress

    Using mediation analysis to account for the effect of Parkinson’s Disease medications on disease progression

    T. Liu, W. Lu, M. Yang, Y. Zhu, T. Dam, W. Hirst (Cambridge, USA)

    Objective: To explore the use of mediation analysis to incorporate L-dopa equivalent daily dose (LEDD) for disease progression of Parkinson’s Disease (PD) in a simulation…
  • 2023 International Congress

    Open-label Extension Study of Long-term Safety and Tolerability of Foslevodopa/Foscarbidopa for Treatment of Advanced Parkinson’s Disease

    V. Fung, J. Aldred, F. Bergquist, E. Danielsen, A. Jeong, J. Jia, A. Spiegel, S. Talapala, C. Carroll (Westmead, Australia)

    Objective: To evaluate long-term safety/tolerability of foslevodopa/foscarbidopa (LDP/CDP) in patients with advanced Parkinson’s disease (aPD) in a phase 3 open-label extension (OLE) study. Background: LDP/CDP…
  • 2023 International Congress

    A non-expensive bidimensional assessment can detect subtle alterations in gait performance in people in the early stages of Parkinson’s disease

    M. Pimentel Piemonte, M. Dalencar, G. Venas, A. Helene, A. Roque, J. Vivas (Sao Paulo, Brazil)

    Objective: To investigate the effectiveness of a two-dimensional gait assessment to identify the decline in gait performance associated with Parkinson's disease progression Background: Gait is…
  • 2023 International Congress

    Continuous estimation of Parkinson’s on-off states using wearable devices

    A. Arnold, T. Jansen, R. Gilron, N. Cottone, J. Sayaan, W. Chen (San Francisco, USA)

    Objective: Utilize passive, continuous data from mobile and wearable devices to estimate on-off states in Parkinson’s patients. Background: The Hauser motor diary is often used…
  • 2023 International Congress

    Detecting Changes in Parkinson’s Motor Symptom Patterns Using Wearable Devices

    A. Arnold, A. Hare, W. Chen, T. Jansen, R. Gilron (San Francsico, USA)

    Objective: Evaluate mobile application and wearable device for detecting clinically significant changes in Parkinson's motor symptoms. Background: Monitoring motor and non-motor symptoms in Parkinson's disease…
  • 2023 International Congress

    Incidence and Predictors of Axial Postural Abnormalities in Parkinson disease: data from the PPMI cohort

    CA. Artusi, C. Campisi, C. Ledda, K. Tsukita, D. Rinaldi, L. Lopiano, M. Fabbri (Torino, Italy)

    Objective: We aim to evaluate the incidence of axial postural abnormalities in patients with Parkinson’s disease (PD) and analyze their demographic and clinical predictors. Background:…
  • 2023 International Congress

    Analysis of excessive daytime sleepiness and clinical findings in Parkinson’s disease

    S. Ueno, N. Nishikawa, H. Takeshige-Amano, T. Ogawa, D. Kamiyama, A. Shindo, K. Shiina, K. Ishikawa, T. Tsunemi, M. Yoshitake, C. Abe, S. Saiki, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: To explore clinical biomarkers associated with excessive daytime sleepiness (EDS) using a real-world cohort database of Parkinson’s disease (PD). Background: Although evidence for current…
  • « Previous Page
  • 1
  • …
  • 127
  • 128
  • 129
  • 130
  • 131
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley